[Consensus of experts on healthcare-associated infection prevention and control of Mpox].

Since May 2022, Mpox has rapidly spread globally and been posing new challenges. There is no specific treatment drug for monkeypox (Mpox), and how to avoid cross infection has become the key to the prevention and control of the Mpox epidemic. However, current guidelines lack systematic recommendations for reducing Mpox transmission risk in medical institutions. Therefore, the National Medical Institution Infection Surveillance System of China, National Training Center of Hospital Infection in China, National Clinical Research Center of Geriatric Disorders organized 64 experts in the fields of healthcare-associated infection control, clinical medicine, disinfection, etc. nationwide to sort out relevant issues and urgently release the consensus of Chinese experts on mpox healthcare-associated infection prevention and control. The main content includes an overview of the Mpox epidemic, pathogenic characteristics, epidemiology, early identification and diagnosis, infection prevention and control strategies and measures in medical institutions, and occupational exposure assessment and treatment, aiming to strengthen healthcare-associated infection prevention and control of Mpox and reduce cross infection.